These clinical practice guidelines are an update of the guidelines published by the Infectious
Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. …

Guidelines for the treatment of persons with influenza virus infection were prepared by an
Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines …

Despite decades of high vaccination coverage, pertussis has remained endemic and reemerged
as a public health problem in many countries in the past 2 decades. Waning of vaccine-…

Background The treatment of symptomatic congenital cytomegalovirus (CMV) disease with
intravenous ganciclovir for 6 weeks has been shown to improve audiologic outcomes at 6 …

Antibody responses develop following SARS-CoV-2 infection, but little is known about their
epitope specificities, clonality, binding affinities, epitopes, and neutralizing activity. We …

Background Safe and effective vaccines against coronavirus disease 2019 (Covid-19) are
urgently needed in young children. Methods We conducted a phase 1 dose-finding study and …

… Dr Englund reported receiving research support from Novartis, Gilead, Chimerix, and Roche;
serving as a consultant for GlaxoSmithKline in 2012-2013; serving on a GlaxoSmithKline …

After its emergence in Wuhan, China, in late November or early December 2019, the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. …

Infection with voriconazole-resistant fungi may become problematic, because organisms with
decreased susceptibility have been noted. Breakthrough fungal infections occurred in 13 of …

IDSA Disclaimer As of the time of this publication, updates have been made to IDSA’s
Guidelines on the Diagnosis of COVID-19. For the most updated version of these guidelines, …